The U.S. Attorney's Office for the Southern District of New York subpoenaed Bristol-Myers Squibb in an investigation of the company's marketing practices for antipsychotic Abilify, according to a company filing with the Securities and Exchange Commission.
Bristol receives subpoena over Abilify marketing
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||